Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NAXITAMAB
- Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
- Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma
- Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Rapid Administration Pilot for Infusing Dinutuximab
- Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.
- Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
Clinical trials list
click for details